rs7256020

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127255.2(NLRP7):​c.3082A>G​(p.Thr1028Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,613,772 control chromosomes in the GnomAD database, including 196 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1028M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.021 ( 96 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 100 hom. )

Consequence

NLRP7
NM_001127255.2 missense

Scores

16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.774

Publications

3 publications found
Variant links:
Genes affected
NLRP7 (HGNC:22947): (NLR family pyrin domain containing 7) This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
NCR1 (HGNC:6731): (natural cytotoxicity triggering receptor 1) Predicted to be involved in cellular defense response; regulation of natural killer cell mediated cytotoxicity; and signal transduction. Predicted to act upstream of or within defense response to virus and detection of virus. Predicted to be located in cell surface. Predicted to be part of SWI/SNF complex. Predicted to be active in plasma membrane. Biomarker of acquired immunodeficiency syndrome; anogenital venereal wart; hepatitis C; and lymphoproliferative syndrome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003714949).
BP6
Variant 19-54923772-T-C is Benign according to our data. Variant chr19-54923772-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 893569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0701 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127255.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP7
NM_001127255.2
MANE Select
c.3082A>Gp.Thr1028Ala
missense
Exon 11 of 11NP_001120727.1Q8WX94-3
NLRP7
NM_001405531.1
c.3082A>Gp.Thr1028Ala
missense
Exon 13 of 13NP_001392460.1Q8WX94-3
NLRP7
NM_139176.4
c.2998A>Gp.Thr1000Ala
missense
Exon 11 of 11NP_631915.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP7
ENST00000592784.6
TSL:1 MANE Select
c.3082A>Gp.Thr1028Ala
missense
Exon 11 of 11ENSP00000468706.1Q8WX94-3
NLRP7
ENST00000588756.5
TSL:1
c.3082A>Gp.Thr1028Ala
missense
Exon 13 of 13ENSP00000467123.1Q8WX94-3
NLRP7
ENST00000340844.6
TSL:1
c.2911A>Gp.Thr971Ala
missense
Exon 10 of 10ENSP00000339491.2Q8WX94-1

Frequencies

GnomAD3 genomes
AF:
0.0212
AC:
3221
AN:
152122
Hom.:
97
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00977
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00598
AC:
1500
AN:
251010
AF XY:
0.00431
show subpopulations
Gnomad AFR exome
AF:
0.0754
Gnomad AMR exome
AF:
0.00497
Gnomad ASJ exome
AF:
0.00238
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000424
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00243
AC:
3549
AN:
1461532
Hom.:
100
Cov.:
31
AF XY:
0.00213
AC XY:
1550
AN XY:
727062
show subpopulations
African (AFR)
AF:
0.0759
AC:
2541
AN:
33470
American (AMR)
AF:
0.00528
AC:
236
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00253
AC:
66
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000336
AC:
29
AN:
86236
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53420
Middle Eastern (MID)
AF:
0.00745
AC:
41
AN:
5500
European-Non Finnish (NFE)
AF:
0.000280
AC:
311
AN:
1112000
Other (OTH)
AF:
0.00537
AC:
324
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
199
398
596
795
994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0212
AC:
3227
AN:
152240
Hom.:
96
Cov.:
32
AF XY:
0.0203
AC XY:
1508
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0722
AC:
2999
AN:
41534
American (AMR)
AF:
0.00976
AC:
149
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68018
Other (OTH)
AF:
0.0180
AC:
38
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
157
314
472
629
786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0149
Hom.:
55
Bravo
AF:
0.0249
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0731
AC:
322
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00687
AC:
834
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hydatidiform mole, recurrent, 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.026
DANN
Benign
0.17
DEOGEN2
Benign
0.017
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0054
N
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.55
N
PhyloP100
-0.77
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.61
N
REVEL
Benign
0.053
Sift
Benign
0.26
T
Sift4G
Benign
0.41
T
Polyphen
0.0
B
Vest4
0.12
MVP
0.16
MPC
0.24
ClinPred
0.00096
T
GERP RS
-2.7
Varity_R
0.028
gMVP
0.080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7256020; hg19: chr19-55435140; API